SAPHO syndrome with unusual cutaneous manifestations treated successfully with etanercept.
Vilar-Alejo
Jaime
J
Dehesa
Luis
L
de la Rosa-del Rey
Pilar
P
Novoa-Medina
Javier
J
Valerón Almazán
Pedro
P
Santana Medina
Néstor
N
Bastida
Jesús
J
D020083:Acquired Hyperostosis Syndrome / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000068800:Etanercept; D005499:Folliculitis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D019698:Hepatitis C, Chronic / Q000150:complications; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011711:Pyoderma / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012867:Skin / Q000187:drug effects / Q000473:pathology; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept